At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
JewelACLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The JewelACL Post Market Clinical Follow Up Study - Multicentre Study of at Least 5 Years Follow up, Looking at Clinical Outcomes in Patients Treated With the JewelACL for Anterior Cruciate Ligament (ACL) Reconstruction
In Brief
An observational study evaluating JewelACL for Anterior Cruciate Ligament Injuries. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The objective of the study is to assess re-rupture rates and patient outcomes from subjects with at least 5 year follow up, treated with the JewelACL device for ACL reconstruction. The impact of fixation type and autograft augmentation will also be assessed. All adverse events related to the JewelACL device will be recorded. This study is Sponsored by Xiros.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnterior Cruciate Ligament Injuries
CountriesPoland
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
First PostedOct 2020
Primary CompletionApr 2021
TodayJul 2026
First PostedOct 8, 2020
Enrollment StartOct 2, 2020
Primary CompletionApr 9, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.7 years ago
Interventions
JewelACLdevice
The JewelACL is a polyester scaffold for anterior cruciate ligament (ACL) reconstruction